1. Home
  2. NVO vs ORCL Comparison

NVO vs ORCL Comparison

Compare NVO & ORCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVO
  • ORCL
  • Stock Information
  • Founded
  • NVO 1923
  • ORCL 1977
  • Country
  • NVO Denmark
  • ORCL United States
  • Employees
  • NVO N/A
  • ORCL N/A
  • Industry
  • NVO Biotechnology: Biological Products (No Diagnostic Substances)
  • ORCL Computer Software: Prepackaged Software
  • Sector
  • NVO Health Care
  • ORCL Technology
  • Exchange
  • NVO Nasdaq
  • ORCL Nasdaq
  • Market Cap
  • NVO 530.0B
  • ORCL 480.2B
  • IPO Year
  • NVO N/A
  • ORCL 1986
  • Fundamental
  • Price
  • NVO $78.71
  • ORCL $160.95
  • Analyst Decision
  • NVO Strong Buy
  • ORCL Buy
  • Analyst Count
  • NVO 6
  • ORCL 27
  • Target Price
  • NVO $134.00
  • ORCL $185.08
  • AVG Volume (30 Days)
  • NVO 10.6M
  • ORCL 7.6M
  • Earning Date
  • NVO 02-05-2025
  • ORCL 03-10-2025
  • Dividend Yield
  • NVO 1.83%
  • ORCL 0.99%
  • EPS Growth
  • NVO 26.84
  • ORCL 13.17
  • EPS
  • NVO 3.17
  • ORCL 4.09
  • Revenue
  • NVO $40,469,178,712.00
  • ORCL $54,933,000,000.00
  • Revenue This Year
  • NVO $24.51
  • ORCL $11.14
  • Revenue Next Year
  • NVO $20.71
  • ORCL $12.58
  • P/E Ratio
  • NVO $24.09
  • ORCL $39.36
  • Revenue Growth
  • NVO 26.15
  • ORCL 6.40
  • 52 Week Low
  • NVO $78.17
  • ORCL $106.51
  • 52 Week High
  • NVO $148.15
  • ORCL $198.31
  • Technical
  • Relative Strength Index (RSI)
  • NVO 27.40
  • ORCL 40.22
  • Support Level
  • NVO $80.05
  • ORCL $152.42
  • Resistance Level
  • NVO $83.99
  • ORCL $168.05
  • Average True Range (ATR)
  • NVO 1.63
  • ORCL 3.02
  • MACD
  • NVO -0.05
  • ORCL -0.06
  • Stochastic Oscillator
  • NVO 5.09
  • ORCL 45.56

About NVO Novo Nordisk A/S

With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting roughly 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.

About ORCL Oracle Corporation

Oracle provides database technology and enterprise resource planning, or ERP, software to enterprises around the world. Founded in 1977, Oracle pioneered the first commercial SQL-based relational database management system. Today, Oracle has more than 400,000 customers in 175 countries.

Share on Social Networks: